MAYO CLINIC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer
Phase 2
Active, not recruiting
- Conditions
- Chromophobe Renal Cell CarcinomaMetastatic Renal Cell CancerPapillary Renal Cell CarcinomaKidney OncocytomaStage IV Renal Cell CancerCarcinoma of the Collecting Ducts of BelliniKidney Medullary CarcinomaRecurrent Renal Cell CarcinomaSarcomatoid Renal Cell Carcinoma
- Interventions
- First Posted Date
- 2013-01-14
- Last Posted Date
- 2023-10-06
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 38
- Registration Number
- NCT01767636
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸Mayo Clinic in Florida, Jacksonville, Florida, United States
🇺🇸Mayo Clinic in Arizona, Scottsdale, Arizona, United States
Effect of Mindful Eating on Body Mass Index in Obese Adolescents
Phase 3
Completed
- Conditions
- Adolescent Obesity
- Interventions
- Behavioral: Standard dietary counsellingBehavioral: Mindful Eating
- First Posted Date
- 2013-01-09
- Last Posted Date
- 2014-01-22
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 21
- Registration Number
- NCT01764113
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Long-Term Outcome Following the Treatment of Pediatric Scoliosis
Not Applicable
Completed
- Conditions
- Adolescent Idiopathic Scoliosis
- Interventions
- Other: Long-term outcomes
- First Posted Date
- 2013-01-04
- Last Posted Date
- 2019-03-19
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 66
- Registration Number
- NCT01760434
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Colchicine and CRP in Atrial Fibrillation and AF Ablation
Phase 2
Completed
- Conditions
- Atrial Fibrillation
- Interventions
- Drug: Colchicine, 0.6 mg PO BIDDrug: Matching placebo
- First Posted Date
- 2012-12-24
- Last Posted Date
- 2019-05-09
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 26
- Registration Number
- NCT01755949
- Locations
- 🇺🇸
Mayo Clinic Florida, Jacksonville, Florida, United States
Effects of Androgen Administration on Inflammation in Normal Women
Not Applicable
Completed
- Conditions
- Hyperandrogenism
- Interventions
- Dietary Supplement: Dehydroepiandrosterone (DHEA)Other: Placebo
- First Posted Date
- 2012-12-20
- Last Posted Date
- 2013-11-18
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 25
- Registration Number
- NCT01753037
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Safety Study of Chimeric Natriuretic Peptide(CD-NP) in Stable LVAD Patients
- First Posted Date
- 2012-12-17
- Last Posted Date
- 2016-08-30
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 14
- Registration Number
- NCT01750905
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Auranofin in Treating Patients With Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Early Phase 1
Completed
- Conditions
- Recurrent Fallopian Tube CancerRecurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity Cancer
- Interventions
- Drug: auranofinOther: laboratory biomarker analysis
- First Posted Date
- 2012-12-12
- Last Posted Date
- 2019-08-02
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 10
- Registration Number
- NCT01747798
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery
Early Phase 1
Completed
- Conditions
- Recurrent MelanomaStage IIA MelanomaStage IIB MelanomaStage IIC MelanomaStage IIIA MelanomaStage IIIB MelanomaStage IIIC MelanomaStage IV Melanoma
- Interventions
- Drug: Montanide ISA 51 VGBiological: MART-1 antigenOther: laboratory biomarker analysisDrug: resiquimod
- First Posted Date
- 2012-12-12
- Last Posted Date
- 2018-10-09
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 30
- Registration Number
- NCT01748747
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
Myocardial Performance at Rest and During Exercise in Heart Failure With Preserved Ejection Fraction
Terminated
- Conditions
- Heart Failure
- Interventions
- Other: Cardiac rehabilitationOther: Myocardial deformation imagingOther: Cardiopulmonary exercise test
- First Posted Date
- 2012-12-12
- Last Posted Date
- 2016-05-17
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 21
- Registration Number
- NCT01747785
- Locations
- 🇺🇸
Mayo Clinic Health System - Franciscan Healthcare, La Crosse, Wisconsin, United States
Effect of Vitamin D Supplementation on Endothelial Function in Obese Adolescents
Phase 1
Completed
- Conditions
- ObesityEndothelial DysfunctionVitamin D Deficiency
- Interventions
- Dietary Supplement: Vitamin D3
- First Posted Date
- 2012-12-10
- Last Posted Date
- 2016-05-02
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 19
- Registration Number
- NCT01746264
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath